Epigenome-wide Association Study of Preterm Birth

描述（由申请人提供）：早产（PTB），通常定义为在妊娠37周之前分娩婴儿，影响12.6%的美国新生儿。预防和治疗PTB的主要障碍是我们对其病因和生物学机制的不完全了解。文献和我们的工作都提供了令人信服的证据，证明PTB受环境和遗传因素及其相互作用的影响。迄今为止，PTB研究在很大程度上忽略了表观基因组学，后者将发育过程中的核重编程机制与环境诱导的生物学变化以及细胞对外部刺激的反应能力联系起来。本提案的中心焦点是确定个体遗传易感性和环境暴露背景下的表观基因组改变，并获得基因组，表观基因组和环境因素影响PTB风险的生物学机制的重要见解。我们建议实现以下目标。目标1：我们将在500名非裔美国母亲中进行表观基因组图谱绘制，其中包括250例自发性非常早产病例和250例足月正常出生体重对照，这些对照来自现有的波士顿出生队列。我们将使用Illumina HumanMethylation27 DNA分析珠芯片进行表观基因组定位。我们将检验出生时获得的母体静脉血样本中DNA甲基化的改变与PTB风险相关的假设。目标2：我们将使用相同的Illumina平台，对目标1中包含的母亲所生的500名婴儿进行表观基因组图谱绘制。我们将检验出生时获得的脐带血样本中DNA甲基化的改变与PTB风险相关的假设。探索性分析：我们将利用波士顿出生队列的广泛数据库同时评估环境，基因组和表观基因组因素的作用以及它们在PTB中的相互作用。我们还将探讨母体和胎儿表观基因组与肺结核的相互作用。这将是第一个结合GWAS对非洲裔美国母婴进行的PTB表观基因组研究，这是一个社会环境逆境患病率高、PTB风险高的人群。该建议具有许多独特的特点，包括通过使用现有的设计良好且表型良好的出生队列进行高成本效益的研究；整合环境、基因组和表观基因组因素的创新方法；一个高度互动和经验丰富的多学科研究团队，具有良好的合作和生产力记录。这项研究有很大的潜力改变我们对PTB的病因学和生物学机制的理解，特别是在高危的城市少数民族人群中，这将对降低美国PTB的发病率和减少早产差异具有重要意义

DESCRIPTION (provided by applicant): Preterm Birth (PTB), commonly defined as delivery of an infant before 37 weeks of gestation, affects 12.6% of all births in the U.S. A major obstacle in preventing and treating PTB has been our incomplete understanding of its etiology and biological mechanisms. Both the literature and our work have provided compelling evidence that PTB is influenced by environmental and genetic factors and their interactions. To date, PTB research has largely omitted epigenomics, which unites mechanisms of nuclear reprogramming during development with environmentally induced biological changes, and the ability of cells to respond to external stimuli. The central focus of this proposal is to identify epigenomic alterations in the context of individual genetic susceptibility and environmental exposures and to gain important insight into the biological mechanisms by which genomic, epigenomic, and environmental factors affect the risk of PTB. We propose to accomplish the following aims. Aim 1: We will conduct epigenomic mapping among 500 African American mothers, including 250 spontaneous very preterm cases and 250 term, normal birth weight controls drawn from the existent Boston Birth Cohort. We will use the Illumina HumanMethylation27 DNA Analysis BeadChip for epigenomic mapping. We will test the hypothesis that alterations of DNA methylation in maternal venous blood samples obtained at birth are associated with the risk of PTB. Aim 2: We will conduct epigenomic mapping among 500 infants born to the mothers included in Aim 1, using the same Illumina platform. We will test the hypothesis that alterations of DNA methylation in cord blood samples obtained at birth are associated with the risk of PTB. Exploratory Analysis: We will utilize the extensive database of the Boston Birth Cohort to simultaneously evaluate the roles of environment, genomic, and epigenomic factors as well as their interactions in PTB. We will also explore the interplay of maternal and fetal epigenome in relation to PTB. This will be the first epigenomic study of PTB in conjunction with GWAS in African American mother-infant pairs, a population with high prevalence of socio-environmental adversities and high risk of PTB. This proposal has many unique features, including a highly cost-efficient study by using an existent well-designed and well-phenotyped birth cohort; an innovative approach to integrate environment, genomic and epigenomic factors in PTB; and a highly interactive and experienced multidisciplinary research team with a track record of collaboration and productivity. This proposed study has a great potential to transform our understanding of the etiology and biological mechanisms of PTB, especially, among high risk inner-city minority populations, which will be of key importance for lowering the incidence of PTB and reducing preterm disparity in the U.S. PUBLIC HEALTH RELEVANCE: In the U.S, more than one out of every eight live births is premature infants (PTB) each year. PTB is a major cause of infant morbidity and mortality and is associated with increased risk for a wide range of short- and long-term health and developmental problems. The central focus of this proposal is to identify maternal and fetal epigenomic alterations in relation to PTB. Findings from this study will help gain important insight into how genomic, epigenomic, and environmental factors affect the risk of PTB.